Login / Signup

Inhibition of bradykinin in SARS-CoV-2 infection: a randomised, double-blind trial of icatibant compared with placebo (ICASARS).

Melanie BaileyDermot LindenOlivia EarleyHong Guo ParkeDaniel Francis McAuleyTunde PetoCliff TaggartJoe Kidney
Published in: BMJ open (2023)
NCT05407597.
Keyphrases
  • double blind
  • phase iii
  • placebo controlled
  • clinical trial
  • phase ii
  • study protocol
  • open label
  • respiratory syndrome coronavirus
  • randomized controlled trial
  • coronavirus disease
  • sars cov